Addus Homecare Co. (NASDAQ:ADUS) has been given a consensus rating of “Buy” by the ten research firms that are presently covering the firm, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $77.88.
A number of equities research analysts have recently commented on ADUS shares. BidaskClub cut shares of Addus Homecare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th. Zacks Investment Research cut shares of Addus Homecare from a “buy” rating to a “hold” rating in a research report on Tuesday, May 7th. ValuEngine cut shares of Addus Homecare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 4th. Finally, Raymond James increased their target price on shares of Addus Homecare from $75.00 to $81.00 and gave the company an “outperform” rating in a research report on Thursday, June 13th.
Shares of NASDAQ ADUS opened at $74.81 on Wednesday. The firm has a 50-day simple moving average of $70.98. The firm has a market capitalization of $983.82 million, a PE ratio of 44.27, a price-to-earnings-growth ratio of 2.30 and a beta of -0.16. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.87 and a quick ratio of 2.87. Addus Homecare has a 52 week low of $55.25 and a 52 week high of $77.82.
In related news, CFO Brian Poff sold 814 shares of the firm’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $67.96, for a total transaction of $55,319.44. Following the completion of the sale, the chief financial officer now directly owns 18,241 shares in the company, valued at $1,239,658.36. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Mark L. First sold 440,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,418,706.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 460,814 shares of company stock valued at $34,061,919. 34.80% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Marshall Wace North America L.P. purchased a new position in Addus Homecare during the first quarter worth about $34,000. Bank of Montreal Can boosted its stake in Addus Homecare by 58.9% during the first quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after buying an additional 202 shares during the period. South Dakota Investment Council purchased a new position in Addus Homecare during the first quarter worth about $83,000. BNP Paribas Arbitrage SA boosted its stake in Addus Homecare by 9,077.3% during the first quarter. BNP Paribas Arbitrage SA now owns 2,019 shares of the company’s stock worth $128,000 after buying an additional 1,997 shares during the period. Finally, NumerixS Investment Technologies Inc purchased a new position in Addus Homecare during the first quarter worth about $138,000. Hedge funds and other institutional investors own 98.99% of the company’s stock.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Recommended Story: Understanding Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.